![glp-1 원리 배부름을 느끼게 하는 비밀, 서울대 연구진이 찾았다! - 연구성과 - 연구 당뇨병 치료제] GLP1 receptor agonists(GLP-1](https://www.snu.ac.kr/webdata/boardimages/kohighlight/img_20240627_003.jpg)
glp-1 원리 배부름을 느끼게 하는 비밀, 서울대 연구진이 찾았다! - 연구성과 - 연구 당뇨병 치료제] GLP1 receptor agonists(GLP-1
Description
Appetite suppressants and GLP-1 medications often get grouped together, but theyre not the same
![glp-1 , ! - - ] GLP1 receptor agonists(GLP-1](https://img1.daumcdn.net/thumb/R800x0/?scode=mtistory2&fname=https%3A%2F%2Fblog.kakaocdn.net%2Fdna%2FcrXsVy%2FbtsGR1i9QNf%2FAAAAAAAAAAAAAAAAAAAAAB_JcsHgdS3PkGybTDkPOkVkXnoJknSwJnjF7mf8PSny%2Fimg.png%3Fcredential%3DyqXZFxpELC7KVnFOS48ylbz2pIh7yKj8%26expires%3D1785509999%26allow_ip%3D%26allow_referer%3D%26signature%3DVWmEbQ1anvf%252BWIebIFIdmDszFxE%253D)
Discussing Maintenance Dosing Options When to Consider Ongoing Low-Dose Therapy Ongoing low-dose therapy can be a good way to go after you reach your first weight loss goal
![glp-1 , ! - - ] GLP1 receptor agonists(GLP-1](https://image.inblog.dev/?url=https%3A%2F%2Fwww.notion.so%2Fimage%2Fattachment%253A6f91bb73-8c3a-4744-998a-c8f67595e77d%253AGLP-1_%2525E1%252584%252580%2525E1%252585%2525B3%2525E1%252586%2525AF%2525E1%252584%252585%2525E1%252585%2525AE%2525E1%252584%25258F%2525E1%252585%2525A1%2525E1%252584%252580%2525E1%252585%2525A9%2525E1%252586%2525AB_%2525E1%252584%25258B%2525E1%252585%2525B2%2525E1%252584%252589%2525E1%252585%2525A1_%2525E1%252584%252591%2525E1%252585%2525A6%2525E1%252586%2525B8%2525E1%252584%252590%2525E1%252585%2525A1%2525E1%252584%25258B%2525E1%252585%2525B5%2525E1%252584%252583%2525E1%252585%2525B3-1_%2525E1%252584%252584%2525E1%252585%2525B3%2525E1%252586%2525BA_%2525E1%252584%25258B%2525E1%252585%2525B4%2525E1%252584%252586%2525E1%252585%2525B5_%2525E1%252584%25258B%2525E1%252585%2525A7%2525E1%252586%2525A8%2525E1%252584%252592%2525E1%252585%2525A1%2525E1%252586%2525AF_%2525E1%252584%252592%2525E1%252585%2525A9%2525E1%252584%252585%2525E1%252585%2525B3%2525E1%252584%252586%2525E1%252585%2525A9%2525E1%252586%2525AB_%2525E1%252584%252580%2525E1%252585%2525AA%2525E1%252586%2525AB%2525E1%252584%252585%2525E1%252585%2525B5_%2525E1%252584%25258B%2525E1%252585%2525B1%2525E1%252584%252580%2525E1%252585%2525A9%2525E1%252584%252587%2525E1%252585%2525B5_%2525E1%252584%252586%2525E1%252585%2525A1%2525E1%252584%25258B%2525E1%252585%2525AE%2525E1%252586%2525AB%2525E1%252584%25258C%2525E1%252585%2525A1%2525E1%252584%252585%2525E1%252585%2525A92.webp%253FspaceId%253D76e36620-c72b-4db0-a817-c73c38ce44a6%3Ftable%3Dblock%26id%3D38883b2d-6504-80bf-b501-ff7a415a5759%26cache%3Dv2&w=828&q=85)
Safety Profile and Tolerability Linagliptins safety and tolerability have been well-documented in clinical trials
![glp-1 , ! - - ] GLP1 receptor agonists(GLP-1](https://www.chosun.com/resizer/v2/ARP7EBUF7BC53BS3BCZQLGLP5U.png?auth=db1004bf8fd852f7c4d3f59d0b8356fd1658cc9ee390462bd8611159c92e1217&width=480&height=524&smart=true)
2023;325:C1144C1153
![glp-1 , ! - - ] GLP1 receptor agonists(GLP-1](https://hyperlab-public-s3.s3.ap-northeast-2.amazonaws.com/mceu_45321724431730427163162_8c79f3962d.png)
